+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Preimplantation Genetic Testing Market Research Report by Technology, by Procedure Type, by Application, by End User, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5124367
  • Report
  • September 2021
  • Region: United States
  • 65 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Preimplantation Genetic Testing Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Preimplantation Genetic Testing Market.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Preimplantation Genetic Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the Preimplantation Genetic Testing Market was studied across Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, Next-Generation Sequencing, Polymerase Chain Reaction, and Single-Nucleotide Polymorphism.
  • Based on Offering, the Preimplantation Genetic Testing Market was studied across Instruments Services, Reagents and Consumables, and Software and Services.
  • Based on Procedure Type, the Preimplantation Genetic Testing Market was studied across Preimplantation Genetic Diagnosis Off-Line Procedure Type and Preimplantation Genetic Screening.
  • Based on Application, the Preimplantation Genetic Testing Market was studied across Aneuploidy, Gender Identification, HLA Typing, Single Gene Disorders, Structural Chromosomal Abnormalities, and X-Linked Disorders. The Structural Chromosomal Abnormalities is further studied across Deletions, Duplications, Inversions, and Translocations.
  • Based on End User, the Preimplantation Genetic Testing Market was studied across Contract Research and Manufacturing Organizations, Hospitals, Diagnostic Labs, and Service Providers, and Research Laboratories & Academic Institutes.
  • Based on State, the Preimplantation Genetic Testing Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Preimplantation Genetic Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Preimplantation Genetic Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Preimplantation Genetic Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Preimplantation Genetic Testing Market?
4. What is the competitive strategic window for opportunities in the United States Preimplantation Genetic Testing Market?
5. What are the technology trends and regulatory frameworks in the United States Preimplantation Genetic Testing Market?
6. What is the market share of the leading vendors in the United States Preimplantation Genetic Testing Market?
7. What modes and strategic moves are considered suitable for entering the United States Preimplantation Genetic Testing Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Offering Outlook
3.5. Procedure Type Outlook
3.6. Application Outlook
3.7. End User Outlook
3.8. State Outlook
3.9. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Preimplantation Genetic Testing Market, by Technology
6.1. Introduction
6.2. Comparative Genomic Hybridization
6.3. Fluorescence in Situ Hybridization
6.4. Next-Generation Sequencing
6.5. Polymerase Chain Reaction
6.6. Single-Nucleotide Polymorphism

7. Preimplantation Genetic Testing Market, by Offering
7.1. Introduction
7.2. Instruments Services
7.3. Reagents and Consumables
7.4. Software and Services

8. Preimplantation Genetic Testing Market, by Procedure Type
8.1. Introduction
8.2. Preimplantation Genetic Diagnosis Off-Line Procedure Type
8.3. Preimplantation Genetic Screening

9. Preimplantation Genetic Testing Market, by Application
9.1. Introduction
9.2. Aneuploidy
9.3. Gender Identification
9.4. HLA Typing
9.5. Single Gene Disorders
9.6. Structural Chromosomal Abnormalities
9.6.1. Deletions
9.6.2. Duplications
9.6.3. Inversions
9.6.4. Translocations
9.7. X-Linked Disorders

10. Preimplantation Genetic Testing Market, by End User
10.1. Introduction
10.2. Contract Research and Manufacturing Organizations
10.3. Hospitals, Diagnostic Labs, and Service Providers
10.4. Research Laboratories & Academic Institutes

11. California Preimplantation Genetic Testing Market
11.1. Introduction

12. Florida Preimplantation Genetic Testing Market
12.1. Introduction

13. Illinois Preimplantation Genetic Testing Market
13.1. Introduction

14. New York Preimplantation Genetic Testing Market
14.1. Introduction

15. Ohio Preimplantation Genetic Testing Market
15.1. Introduction

16. Pennsylvania Preimplantation Genetic Testing Market
16.1. Introduction

17. Texas Preimplantation Genetic Testing Market
17.1. Introduction

18. Competitive Landscape
18.1. FPNV Positioning Matrix
18.1.1. Quadrants
18.1.2. Business Strategy
18.1.3. Product Satisfaction
18.2. Market Ranking Analysis
18.3. Market Share Analysis, By Key Player
18.4. Competitive Scenario
18.4.1. Merger & Acquisition
18.4.2. Agreement, Collaboration, & Partnership
18.4.3. New Product Launch & Enhancement
18.4.4. Investment & Funding
18.4.5. Award, Recognition, & Expansion

19. Company Usability Profiles

20. Appendix
20.1. Discussion Guide
20.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 3. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2020 (USD MILLION)
FIGURE 4. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE TYPE, 2020 (USD MILLION)
FIGURE 5. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION , 2020 (USD MILLION)
FIGURE 6. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER , 2020 (USD MILLION)
FIGURE 7. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 8. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 9. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: MARKET DYNAMICS
FIGURE 10. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 11. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 13. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2026 (USD MILLION)
FIGURE 18. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 19. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2026 (USD MILLION)
FIGURE 20. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 21. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM, 2018-2026 (USD MILLION)
FIGURE 22. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 23. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2020 VS 2026 (%)
FIGURE 24. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2020 VS 2026 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2026
FIGURE 26. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS SERVICES, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS SERVICES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 28. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 30. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2026 (USD MILLION)
FIGURE 31. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 32. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE TYPE, 2020 VS 2026 (%)
FIGURE 33. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE TYPE, 2026
FIGURE 35. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS OFF-LINE PROCEDURE TYPE, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS OFF-LINE PROCEDURE TYPE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC SCREENING, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC SCREENING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION , 2020 VS 2026 (%)
FIGURE 40. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION , 2020 VS 2026 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION , 2026
FIGURE 42. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY ANEUPLOIDY, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY ANEUPLOIDY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 44. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY GENDER IDENTIFICATION, 2018-2026 (USD MILLION)
FIGURE 45. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY GENDER IDENTIFICATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 46. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HLA TYPING, 2018-2026 (USD MILLION)
FIGURE 47. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HLA TYPING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 48. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE GENE DISORDERS, 2018-2026 (USD MILLION)
FIGURE 49. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE GENE DISORDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 50. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STRUCTURAL CHROMOSOMAL ABNORMALITIES, 2018-2026 (USD MILLION)
FIGURE 51. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STRUCTURAL CHROMOSOMAL ABNORMALITIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 52. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DELETIONS, 2018-2026 (USD MILLION)
FIGURE 53. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DELETIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 54. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DUPLICATIONS, 2018-2026 (USD MILLION)
FIGURE 55. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DUPLICATIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 56. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INVERSIONS, 2018-2026 (USD MILLION)
FIGURE 57. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INVERSIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 58. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TRANSLOCATIONS, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TRANSLOCATIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 60. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY X-LINKED DISORDERS, 2018-2026 (USD MILLION)
FIGURE 61. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY X-LINKED DISORDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 62. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER , 2020 VS 2026 (%)
FIGURE 63. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER , 2020 VS 2026 (USD MILLION)
FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER , 2026
FIGURE 65. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY CONTRACT RESEARCH AND MANUFACTURING ORGANIZATIONS, 2018-2026 (USD MILLION)
FIGURE 66. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY CONTRACT RESEARCH AND MANUFACTURING ORGANIZATIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 67. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HOSPITALS, DIAGNOSTIC LABS, AND SERVICE PROVIDERS, 2018-2026 (USD MILLION)
FIGURE 68. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HOSPITALS, DIAGNOSTIC LABS, AND SERVICE PROVIDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 69. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 70. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 71. CALIFORNIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. FLORIDA PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. ILLINOIS PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. NEW YORK PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. OHIO PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. PENNSYLVANIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. TEXAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 79. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE TYPE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS OFF-LINE PROCEDURE TYPE, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC SCREENING, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION , 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY ANEUPLOIDY, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY GENDER IDENTIFICATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HLA TYPING, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE GENE DISORDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STRUCTURAL CHROMOSOMAL ABNORMALITIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DELETIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DUPLICATIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INVERSIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TRANSLOCATIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY X-LINKED DISORDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER , 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY CONTRACT RESEARCH AND MANUFACTURING ORGANIZATIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 30. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HOSPITALS, DIAGNOSTIC LABS, AND SERVICE PROVIDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 32. CALIFORNIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. FLORIDA PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. ILLINOIS PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. NEW YORK PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. OHIO PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. PENNSYLVANIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. TEXAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: SCORES
TABLE 40. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: BUSINESS STRATEGY
TABLE 41. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: PRODUCT SATISFACTION
TABLE 42. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: RANKING
TABLE 43. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 44. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: MERGER & ACQUISITION
TABLE 45. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: INVESTMENT & FUNDING
TABLE 48. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll